Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

March 1, 2029

Study Completion Date

March 1, 2029

Conditions
SplenomegalySplenectomyThrombopeniaInterstitial Lung Disease (ILD)Hypocholesterolemia
Interventions
PROCEDURE

Blood sampling for dosage

4ml blood sample to measure acid sphingomyelinase enzyme activity and LysoSM, if required.

Trial Locations (1)

75020

Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris

All Listed Sponsors
collaborator

Bichat Hospital

OTHER

collaborator

Hospital Avicenne

OTHER

collaborator

Rennes University Hospital

OTHER

collaborator

Bicetre Hospital

OTHER

collaborator

University Hospital, Marseille

OTHER

collaborator

Tenon Hospital, Paris

OTHER

collaborator

Centre Hospitalier Universitaire Dijon

OTHER

collaborator

University Hospital, Lille

OTHER

collaborator

Hospices Civils de Lyon

OTHER

lead

Wladimir MAUHIN, Dr

OTHER

NCT06869499 - Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung Disease | Biotech Hunter | Biotech Hunter